Weei/nesn Jimmy Fund Radio-telethon

Deborah B. Goldberg is the Massachusetts State Treasurer and Receiver General. In that role she is responsible for the state’s cash and debt management, unclaimed property, and chairs state boards and commissions, including the Massachusetts School Building Authority, the Pension Reserves Investment Management Board, the State Board of Retirement, Massachusetts State Lottery Commission, and theMassachusetts Clean Water Trust. In 2015, she established the new Office of Economic Empowerment, the first of its kind in the country, and chairs its Economic Empowerment Trust Fund. Treasurer Goldberg is the former President of the National Association of State Treasurers and is the Co-Chair of the National Institute of Public Finance.

Bruins' Trent Frederic and Jeremy Swayman joins the Jimmy Fund to preview the upcoming season and how the team will adapt to life without Patrice Bergeron and David Krejci.

July of 2017, Laurie noticed a lump on the right side of her stomach but didn’t think much of it until her husband noticed it too. He advised her to see her primary care physician and she ended up going the next day. After the initial visit, she was then sent in for CT scan because her blood work results raised concern. The scan revealed a tumor on her colon that had spread to her liver. Laurie recalls feeling disbelief because of how well things were going for her in May of 2017 – she had just obtained her naturalization certificate and had started to lose weight with less effort. She says it was difficult to accept, but she knew everything would be okay because of her faith. Her treatment, chemotherapy and 5 sessions of radiation, began a few months later in August of 2017. Overall, she’s had no major issues and has been able to take some breaks from treatment, the longest being 12 months last year. Colorectal cancer is the third most commonly diagnosed cancer in both men and women, excluding skin cancers.

After blood work results revealed a low white blood cell count, Deidre was referred to a hematologist/oncologist. They ruled out an autoimmune disorder as the potential cause, but discovered SMM, a pre-blood cancer. From there, she met with Dr. Ghobrial at the Center for Prevention of Progression at Dana-Farber in July of 2022 and learned about an immunotherapy clinical trial. The drug works to fight myeloma cells before they become too prevalent in the body. Deidre started treatment in August of 2022, stayed in the hospital for 5 days, and hassince had weekly treatments, then every other week, to now monthly. She receives asubcutaneous injection in the abdomen and will complete the clinical trial in one more year. She describes Dr. Ghobrial as a trailblazer, treating patients early when they have a precursor disorder to try to prevent disease progression into multiple myeloma. Multiple myeloma is a relatively uncommon cancer. In the United States, the lifetime risk of getting multiple myeloma is 1 in 132, or

Red Sox Chief Baseball Officer Chaim Bloom looks at the final push towards the playoffs and what he's looking for in terms of improvements for the final month of the regular season.

Red Sox relievers Chris Martin and Kenley Jansen talk about their experience being a part of the Jimmy Fund in their first season in Boston and how technology will start to take over baseball.

Grace was diagnosed with acute lymphoblastic leukemia (ALL) in October 2022. She had always been full of spunk and energy, ready to perform a song and dance at the drop of a hat. Her parents noticed that she had been particularly tired and lethargic, which wasn't her usual self. They thought she might have mono or Lyme disease, so they took her to the doctor, but tests revealed she had ALL. She is on a two-year chemotherapy treatment plan, of which she is in the middle. ALL is the most common type of childhood cancer. It most often occurs in children ages 3 to 5 and affects slightly more boys than girls. About 3,000 people younger than age 20 are found to have ALL each year in the United States.

After difficulty breathing, Megan subsequently tested positive for COVID, which doctors initially thought was the cause of her symptoms. But her oxygen saturation, or the balance of oxygen in her blood, remained low, so she underwent additional testing. Then, a chest x-ray revealed two liters of fluid in her lungs. After a fusion biopsy, she was officially diagnosed with Stage 4 breast cancer in June of 2022. Since then, Megan has been treated with hormonal therapy and continues to receivetreatment today. She also has tremendous support from her family members, both of whom also work in the medical professions. Her mother is a nurse and her father is a thoracic oncologist. A collaegue of Megan’s father reccomended Dr. Ann Partridge at Dana-Farber because she founded and directs Young and Strong, a program specifically for young women with breast cancer. Dr. Partridge is part of Megan’s care team today as her oncologist. Ann Partridge is a medical oncologist and clinical researcher focused on improving the car

Pat is the general manager of Applebee’s in Cranston, RI and has worked for the brand for 11 years. Applebee’s raised over $60,000 for the Jimmy Fund during our in-store campaign in May and golf tournament. He has personally lost his mother, father, and brother to cancer.

Marline was diagnosed with invasive ductal carcinoma, a type of breast cancer. Marline always had regular mammographs. But after the birth of son, she continued to lactate, she shared with the doctors, and they continued to monitor and noted that she had dense breasts. After Marline's nephew jumped on her and landed on her right breast, she said she was in indescribable pain, worst pain she has ever had. She went to see her doctor and a September 2022 mammogram showed some type of abnormality and a biopsy on October 5 confirmed the cancer. Selected Dana-Farber because they are the best. From the minute she hit Dana-Farber’s door – wonderful people have been the greatest advocates for her. According to BreastCancer.org, one in eight women in the United States will be diagnosed with breast cancer in her lifetime. Breast cancer is the most common cancer in women in the United States, except for skin cancers. It is about 30% (or 1 in 3) of all new female cancers each year. On average, every 2 minutes a woman is d

In 2012, Barry noticed some swelling on his neck, so he made an appointment to see his primary care physician. An x-ray and CT scan lead to follow-up appointments with various specialists until he was diagnosed with Stage 3B non-small cell lung cancer. Barry was initially going to get treatment at another institution but stopped at Dana-Farber to get a second opinion from Dr. Lathan. He recalls Dr. Lathan telling him they’d use all the tools in the toolbox and fight as hard as he could. From there, Barry knew he was in the right place. The treatment caused his tumors to shrink significantly and gave him his life back. Today, he’s no longer in active treatment, but returns to Dana-Farber for a follow-up every 6 months. Barry also volunteers as a patient advocate at Dana-Farber and Brigham & Women’s Hospital. He echoes that everything done at Dana-Farber is done with love and integrity, and he’s honored to be a part of that too. Lung cancer is the second most common cancer (not counting skin cancer) in both

Mary Lee went to her PCP following leg and back pain she was experiencing in June2017. It was initially chalked up as possibly sciatica, but when the pain persisted, she went to an orthopedic surgeon, and a subsequent MRI revealed cancer. Her doctors said her cancer was stage 4 and recommended she come to Dana-Farber. Types and length of treatments: She started treatment in 2017, went for chemo everyweek until 2019. Her cancer went into remission and then is often the case with her type of disease it returned and had spread. She went on a couple of different clinical trials which have helped keep her cancer at bay. She is feeling great today. She is very happy she ended up at Dana-Farber and is simply “glad to still be here.” Ovarian cancer isn’t diagnosed until it has progressed to an advanced stage. This is because ovarian cancer symptoms either aren’t apparent in the early stages of the disease or they mimic common stomach and digestive issues that are often mistaken for minor ailments. Ursula A. Matulonis

Head coach of the BC Eagles Jeff Hafley discusses his connection to the Jimmy Fund regarding his family and the upcoming football season and what he likes the most about his group.

Red Sox pitcher Nick Pivetta joins to talk about how he ingrained himself to the Jimmy Fund when he came to Boston and gives his insights from the clubhouse as the team's chase for the playoffs gets a little tougher.

Following some discomfort, Natalia underwent a colonoscopy in February of 2022. She was officially diagnosed with colon cancer after the procedure. Her doctors also believed that the cancer may be hereditary in nature because Natalia’s mother had uterine cancer. Additional genetic testing also confirmed that she had Lynch Syndrome, a genetic condition that greatly increases a person’s chance of developing cancer, including colon cancer. After the diagnosis, she underwent tumor removal surgery at Dana-Farber, and then started on a chemotherapy and immunotherapy combination treatment. Immunotherapy is a newer type of cancer treatment that allows the body’s own immune system to recognize and destroy cancer cells. She had been traveling back and forth from Seattle to Boston for treatment, which she completed in June. Today,she is cancer-free. In her free time, Natalia enjoys going to museums and shops, like Newbury Street when she’s in Boston. This visit is her daughter’s first time coming to see Boston! Natalie

Red Sox manager Alex Cora joins to talk about what the Jimmy Fund means to him and how he is approaching the last month of the regular season as the playoff chase gets more and more tighter.

Joe Andruzzi reflects on his fight that forced him to retire from football and the continued work from his foundation "The Joe Andruzzi Foundation."

Magnolia joined Dana-Farber in 2007 and currently serves as the Vice President of Community Health. In this role, she is charged with helping the Institute carry out its community benefits mission through the delivery of evidence-based cancer prevention, screening, and early detection programs. Magnolia and her team work with city and state health departments, community partners, and Boston-based coalitions to assess and monitor the needs of local residents with respect to cancercontrol. They are on the front lines of supporting and collaborating on programs designed to eliminate disparities in breast, colon, and skin cancer; educate diverse populations about tobacco cessation, human papillomavirus (HPV) prevention and screening.

Elevated PSA (prostate specific antigen levels) lead to Henry undergoing a biopsy, which revealed stage IV prostate cancer. He was officially diagnosed on August 13, 2021. He went to the doctor after getting a hemorrhoid while offshore fishing. His primary care doctor was the one who suggested also checking his PSA levels as a routine matter of care. A month after diagnosis, Henry underwent surgery toremove his prostate, seminal vesicles, and 27 pelvic lymph nodes, 8 of which were metastatic. After the surgery, surgical margins were deemed positive, meaning cancer cells were still present on the edges of the tissue. In response, Henry started systemic drug therapy in November and later, 40 sessions of radiation from January through March 2022. He is still in treatment and continuing the systemic drug therapy. Henry points out that he feels like more than a number at Dana-Farber because of the continued care and compassion that he receives: ranging from the nurses to radiation therapy technicians. Traveling in

In early March of 2018, at age 58, Roger Miller went to a local doctor’s office in Maine for outpatient surgery. He’d been putting off getting what he’d thought was a cyst removed from the back of his head. Miller, who at the time was working as a maritime consultant, wasn’t all that worried. He and his wife, Lisa, had just returned from backcountry skiing in British Columbia. He felt fine. The pathology report that came a few days later suggested otherwise. Miller had stage IV melanoma. A call to a family friend pointed them to Dana-Farber. After a series of evaluations in late March, Miller’s oncologist, Elizabeth Buchbinder, MD, delivered round two of unfathomable news: The melanoma had spread to his pelvis, lungs, and brain. Today, he is cancer-free. He’s not taking any medication and he goes in for scans twice a year. “There’s no evidence of the cancer. There are no side effects. There’s no anything,” he says. “It worked.” Elizabeth Buchbinder is a clinical oncologist at Dana Farber Cancer Institute spec